Karen Sauve

Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus–Induced Murine Bacteremia

Raymond Schuch, Han M. Lee, Brent Schneider et al. · The Journal of Infectious Diseases · 2013 · 190 citations · Full text

The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-Resistant<i>Staphylococcus aureus</i>Bacteriolysis

Chiara Indiani, Karen Sauve, Assaf Raz et al. · Antimicrobial Agents and Chemotherapy · 2019 · 66 citations · Full text

Exebacase Demonstrates <i>In Vitro</i> Synergy with a Broad Range of Antibiotics against both Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus

Aubrey Watson, Karen Sauve, Cara Cassino et al. · Antimicrobial Agents and Chemotherapy · 2019 · 38 citations · Full text

Antimicrobial Activity of Exebacase (Lysin CF-301) against the Most Common Causes of Infective Endocarditis

Aubrey Watson, Jun Taek Oh, Karen Sauve et al. · Antimicrobial Agents and Chemotherapy · 2019 · 37 citations · Full text

Rapid bacteriolysis of <i>Staphylococcus aureus</i> by lysin exebacase

Xavier Vila‐Farrés, Karen Sauve, Jun Kyun Oh et al. · Microbiology Spectrum · 2023 · 12 citations · Full text